HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthew R Hassler Selected Research

Non-alcoholic Fatty Liver Disease

1/2022An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthew R Hassler Research Topics

Disease

3Huntington Disease (Huntington's Disease)
01/2019 - 12/2015
3Neurodegenerative Diseases (Neurodegenerative Disease)
10/2016 - 12/2015
2Nervous System Diseases (Neurological Disorders)
01/2019 - 10/2016
1Non-alcoholic Fatty Liver Disease
01/2022
1Fatty Liver
01/2022
1Fibrosis (Cirrhosis)
01/2022
1Inflammation (Inflammations)
01/2022
1Liver Diseases (Liver Disease)
01/2022
1Obesity
01/2022
1Pre-Eclampsia (Preeclampsia)
11/2018

Drug/Important Bio-Agent (IBA)

2Small Interfering RNA (siRNA)IBA
01/2019 - 08/2016
2Messenger RNA (mRNA)IBA
01/2019 - 12/2015
2OligonucleotidesIBA
10/2016 - 12/2015
1Triglycerides (Triacylglycerol)IBA
01/2022
1DiglyceridesIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2019
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2018

Therapy/Procedure

2Therapeutics
10/2016 - 08/2016
1RNAi Therapeutics
01/2022